Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Ptc Therapeutics Inc patents


Recent patent applications related to Ptc Therapeutics Inc. Ptc Therapeutics Inc is listed as an Agent/Assignee. Note: Ptc Therapeutics Inc may have other listings under different names/spellings. We're not affiliated with Ptc Therapeutics Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "P" | Ptc Therapeutics Inc-related inventors


Compositions of 1,2,4-oxadiazole benzoic acid compounds and methods for their use

Novel 1,2,4-oxadiazole benzoic acid compounds, methods of using and pharmaceutical compositions comprising an 1,2,4-oxadiazole benzoic acid derivative are disclosed. The methods include methods of treating or preventing a disease ameliorated by modulation of premature translation termination or nonsense-mediated mrna decay, or ameliorating one or more symptoms associated therewith.. ... Ptc Therapeutics Inc

Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy

The present invention relates to specific doses of and dosing regimens for using a 1,2,4-oxadiazole benzoic acid compound in treating or preventing diseases associated with nonsense mutations. In particular, the invention relates to specific doses and dosing regimens for the use of 3-[5-(2-fluoro-phenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid in mammals having diseases associated with nonsense mutations.. ... Ptc Therapeutics Inc

Compounds for nonsense suppression, and methods for their use

The present invention relates to methods, compounds, and compositions for treating or preventing diseases associated with nonsense mutations in an mrna by administering the compounds or compositions of the present invention. More particularly, the present invention relates to methods, compounds, and compositions for suppressing premature translation termination associated with a nonsense mutation in an mrna.. ... Ptc Therapeutics Inc

Ptc Therapeutics, Inc.

. . ... Ptc Therapeutics Inc

Methods of treatment using a 1,2,4-oxadiazole benzoic acid

Provided herein are methods of treating, preventing, ameliorating or managing mucopolysaccharidosis (nmmps) disease, comprising administering a 1,2,4-oxadiazole benzoic acid to a patient having a nmmps. In particular, provided herein are methods of treating, preventing, ameliorating or managing a mps.. ... Ptc Therapeutics Inc

Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic acid

Provided herein are pharmaceutical compositions, which comprise a 1,2,4-oxadiazole benzoic acid or a pharmaceutically acceptable salt thereof. Further provided herein are certain pharmaceutically acceptable salts of a 1,2,4-oxadiazole benzoic acid and methods for making the same. ... Ptc Therapeutics Inc

Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy

The present invention relates to specific doses of and dosing regimens for using a 1,2,4-oxadiazole benzoic acid compound in treating or preventing diseases associated with nonsense mutations. In particular, the invention relates to specific doses and dosing regimens for the use of 3-[5-(2-fluoro-phenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid in mammals having diseases associated with nonsense mutations.. ... Ptc Therapeutics Inc

Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease

The present invention relates to specific doses of and dosing regimens for using a 1,2,4-oxadiazole benzoic acid compound in treating or preventing diseases associated with nonsense mutations. In particular, the invention relates to specific doses and dosing regimens for the use of 3-[5-(2-fluoro-phenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid in mammals having diseases associated with nonsense mutations.. ... Ptc Therapeutics Inc

Methods for modulating the amount of rna transcripts

Described herein are methods for modulating the amount of a gene product and compounds for use in such methods. More particularly, described herein are methods for modulating the amount of an rna transcript or protein product as the result of gene expression and compounds for use in such methods.. ... Ptc Therapeutics Inc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Ptc Therapeutics Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Ptc Therapeutics Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###